Paediatric autoimmune encephalopathies: Clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 7, 2013, Pages 748-755

  Hacohen, Yael ^a   Wright, Sukhvir ^a   Waters, Patrick ^a   Agrawal, Shakti ^b   Carr, Lucinda ^c   Cross, Helen ^c   De Sousa, Carlos ^c   DeVile, Catherine ^c   Fallon, Penny ^d   Gupta, Rajat ^b   Hedderly, Tammy ^e,f   Hughes, Elaine ^e,f   Kerr, Tim ^d   Lascelles, Karine ^e   Lin, Jean Pierre ^e   Philip, Sunny ^b   Pohl, Keith ^e   Prabahkar, Prab ^c   Smith, Martin ^b   Williams, Ruth ^e   Clarke, Antonia ^d   Hemingway, Cheryl ^c   Wassmer, Evangeline ^b   Vincent, Angela ^a   Lim, Ming J ^a,e,f   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d ST GEORGE S HOSPITAL   (United Kingdom)

^e EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GLYCINE RECEPTOR; IMMUNOGLOBULIN; MYCOPHENOLIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RITUXIMAB; VOLTAGE GATED POTASSIUM CHANNEL;

ADOLESCENT; ALLERGIC ENCEPHALOMYELITIS; ANTIBODY DETECTION; ARTICLE; BEHAVIOR CHANGE; BLOOD SAMPLING; BRAIN INFECTION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONFUSION; CONTROLLED STUDY; EEG ABNORMALITY; FEMALE; HALLUCINATION; HUMAN; IMMUNOTHERAPY; INTENSIVE CARE; MALE; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANKIN SCALE; SCHOOL CHILD; SEIZURE;

EID: 84878748946     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-303807     Document Type: Article

References (34)

1. Davies E, Connolly DJ, Mordekar SR. Encephalopathy in children: an approach to assessment and management. Arch Dis Child 2012;97:452-8.
2. Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis 2003;36:731-42. (Pubitemid 36337977)
3. Granerod J, Cunningham R, Zuckerman M, et al. Causality in acute encephalitis: defining aetiologies. Epidemiol Infect 2010;138:783-800.
4. Vincent A, Bien CG, Irani SR, et al. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011;10:759-72.
5. Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74.
6. Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 2011;77:179-89.
7. Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009;66:11-18.
8. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010;133:1655-67.
9. Dale RC, Irani SR, Brilot F, et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol 2009;66:704-9.
10. Florance-Ryan N, Dalmau J. Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents. Curr Opin Pediatr 2010;22:739-44.
11. Suleiman J, Brenner T, Gill D, et al. Immune-mediated steroid-responsive epileptic spasms and epileptic encephalopathy associated with VGKC-complex antibodies. Dev Med Child Neurol 2011;53:1058-60.
12. Suleiman J, Brenner T, Gill D, et al. VGKC antibodies in pediatric encephalitis presenting with status epilepticus. Neurology 2011;76:1252-5.
13. Dhamija R, Renaud DL, Pittock SJ, et al. Neuronal voltage-gated potassium channel complex autoimmunity in children. Pediatr Neurol 2011;44:275-81.
14. Haberlandt E, Bast T, Ebner A, et al. Limbic encephalitis in children and adolescents. Arch Dis Child 2011;96:186-91.
15. Illingworth MA, Hanrahan D, Anderson CE, et al. Elevated VGKC-complex antibodies in a boy with fever-induced refractory epileptic encephalopathy in school-age children (FIRES). Dev Med Child Neurol 2011;53:1053-7.
16. Iyer A, McTague A, Curran A, et al. VGKC-complex antibody mediated encephalitis presenting with psychiatric features and neuroleptic malignant syndrome - further expanding the phenotype. Dev Med Child Neurol 2012 Jul 22;54:575-6.
17. Hacohen Y, Wright S, Siddiqui A, et al. A clinico-radiological phenotype of voltage-gated potassium channel complex antibody-mediated disorder presenting with seizures and basal ganglia changes. Dev Med Child Neurol 2012. doi:10.1111/j.1469-8749.2012.04366.x. [Epub ahead of print].
18. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010;10:835-44.
19. Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012;54:899-904.
20. Bigi S, Fischer U, Wehrli E, et al. Acute Ischemic Stroke in Children versus Young Adults. Ann Neurol 2011;70:245-54.
21. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734-48.
22. Hutchinson M, Waters P, McHugh J, et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology 2008;71:1291-2.
23. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701-12. (Pubitemid 38295483)
24. Vincent A, Grimaldi LM, Martino G, et al. Antibodies to 125I-glutamic acid decarboxylase in patients with stiffman syndrome. J Neurol Neurosurg Psychiatry 1997;62:395-7.
25. Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36. (Pubitemid 46214241)
26. Turner MR, Irani SR, Leite MI, et al. Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology 2011;77:439-43.
27. Piotrowicz A, Thumen A, Leite MI, et al. A case of glycine-receptor antibody-associated encephalomyelitis with rigidity and myoclonus (PERM): clinical course, treatment and CSF findings. J Neurol 2011;258:2268-70.
28. Gable MS, Gavali S, Radner A, et al . Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009;28:1421-9.
29. Prüss H, Finke C, Höltje M, et al . NMDA receptor antibodies in herpes simplex encephalitis. Ann Neurol 2012. doi:10.1002/ana.23689.
30. Iizuka T, Yoshii S, Kan S, et al. Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol 2010;257:1686-91.
31. Bein CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 2012;135:1622-38.
32. Wong-Kisiel LC, McKeon A, Wirrell EC. Autoimmune encephalopathies and epilepsies in children and teenagers. Can J Neurol Sci 2012;39:134-44.
33. Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001;50:73-8.
34. Dale RC, Merheb V, Pillai S, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 2012;135:1-16.